Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells

Cancer Letters

Volumn 337, Issue 2, 2013, Pages 266-275

  Wu, Jun ^a   Wang, Yingming ^a   Qiao, Xiaojing ^a   Saiyin, Hexige ^a   Zhao, Shenan ^a   Qiao, Shouyi ^a   Wu, Yanhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer metastasis suppressor 1 (BRMS1); Hepatocellular carcinoma (HCC); Transcript variant

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASE MISPAIRING; BIOACCUMULATION; BRMS1 GENE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EXON; FEMALE; GENE EXPRESSION; GENE LOCATION; GENETIC CODE; GENETIC STABILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TUMOR GROWTH;

APOPTOSIS; BREAST CANCER METASTASIS SUPPRESSOR 1 (BRMS1); HEPATOCELLULAR CARCINOMA (HCC); TRANSCRIPT VARIANT;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CLONING, MOLECULAR; FEMALE; GENES, REPORTER; GENETIC VARIATION; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR BURDEN;

EID: 84880514315     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.04.030     Document Type: Article

References (47)

1. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited, Nature reviews. Cancer 2003, 3:453-458.
2. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
3. Yoshida B.A., Sokoloff M.M., Welch D.R., Rinker-Schaeffer C.W. Metastasis-suppressor genes: a review and perspective on an emerging field. J. Natl Cancer Inst. 2000, 92:1717-1730.
4. Steeg P.S., Bevilacqua G., Kopper L., Thorgeirsson U.P., Talmadge J.E., Liotta L.A., Sobel M.E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst. 1988, 80:200-204.
5. Bodenstine T.M., Welch D.R. Metastasis suppressors and the tumor microenvironment. Cancer Microenviron: Off. J. Int. Cancer Microenviron. Soc. 2008, 1:1-11.
6. Seraj M.J., Samant R.S., Verderame M.F., Welch D.R. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 2000, 60:2764-2769.
7. Shevde L.A., Samant R.S., Goldberg S.F., Sikaneta T., Alessandrini A., Donahue H.J., Mauger D.T., Welch D.R. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp. Cell Res. 2002, 273:229-239.
8. Zhang S., Lin Q.D., Di W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int. J. Gynecol. Cancer 2006, 16:522-531.
9. Smith P.W., Liu Y., Siefert S.A., Moskaluk C.A., Petroni G.R., Jones D.R. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett. 2009, 276:196-203.
10. Samant R.S., Debies M.T., Hurst D.R., Moore B.P., Shevde L.A., Welch D.R. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett. 2006, 235:260-265.
11. Meehan W.J., Samant R.S., Hopper J.E., Carrozza M.J., Shevde L.A., Workman J.L., Eckert K.A., Verderame M.F., Welch D.R. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J. Biol. Chem. 2004, 279:1562-1569.
12. Samant R.S., Seraj M.J., Saunders M.M., Sakamaki T.S., Shevde L.A., Harms J.F., Leonard T.O., Goldberg S.F., Budgeon L., Meehan W.J., Winter C.R., Christensen N.D., Verderame M.F., Donahue H.J., Welch D.R. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin. Exp. Metastasis 2000, 18:683-693.
13. DeWald D.B., Torabinejad J., Samant R.S., Johnston D., Erin N., Shope J.C., Xie Y., Welch D.R. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Res. 2005, 65:713-717.
14. Vaidya K.S., Harihar S., Phadke P.A., Stafford L.J., Hurst D.R., Hicks D.G., Casey G., DeWald D.B., Welch D.R. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J. Biol. Chem. 2008, 283:28354-28360.
15. Cicek M., Fukuyama R., Welch D.R., Sizemore N., Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res. 2005, 65:3586-3595.
16. Liu Y., Smith P.W., Jones D.R. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol. Cell. Biol. 2006, 26:8683-8696.
17. Samant R.S., Clark D.W., Fillmore R.A., Cicek M., Metge B.J., Chandramouli K.H., Chambers A.F., Casey G., Welch D.R., Shevde L.A. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Mol. Cancer 2007, 6:6.
18. Yang J., Zhang B., Lin Y., Yang Y., Liu X., Lu F. Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. Cancer Lett. 2008, 269:46-56.
19. Sheng X.J., Zhou Y.Q., Song Q.Y., Zhou D.M., Liu Q.C. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression. Oncol. Rep. 2012, 27:1011-1018.
20. Cicek M., Fukuyama R., Cicek M.S., Sizemore S., Welch D.R., Sizemore N., Casey G. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Clin. Exp. Metastasis 2009, 26:229-237.
21. Wu Y., Jiang W., Wang Y., Wu J., Saiyin H., Qiao X., Mei X., Guo B., Fang X., Zhang L., Lou H., Wu C., Qiao S. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression. PLoS ONE 2012, 7:e42976.
22. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., Rodes J. E.P.o.E.o. HCC, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001, 35:421-430.
23. Schwartz M., Roayaie S., Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat. Clin. Pract. Oncol. 2007, 4:424-432.
24. Rivera J., Megias D., Navas C., Bravo J. Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS ONE 2009, 4:e6433.
25. Sorg G., Stamminger T. Mapping of nuclear localization signals by simultaneous fusion to green fluorescent protein and to beta-galactosidase. Biotechniques 1999, 26:858-862.
26. Hicks D.G., Yoder B.J., Short S., Tarr S., Prescott N., Crowe J.P., Dawson A.E., Budd G.T., Sizemore S., Cicek M., Choueiri T.K., Tubbs R.R., Gaile D., Nowak N., Accavitti-Loper M.A., Frost A.R., Welch D.R., Casey G. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clin. Cancer Res. 2006, 12:6702-6708.
27. Frolova N., Edmonds M.D., Bodenstine T.M., Seitz R., Johnson M.R., Feng R., Welch D.R., Frost A.R. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour biol.: J. Int. Soc. Oncodevelop. Biol. Med. 2009, 30:148-159.
28. Siebert S., Fielding C.A., Williams B.D., Brennan P. Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression. FEBS Lett. 2005, 579:5193-5198.
29. Kucharczak J., Simmons M.J., Fan Y., Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003, 22:8961-8982.
30. Hurst D.R., Xie Y., Edmonds M.D., Welch D.R. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clin. Exp. Metastasis 2009, 26:89-96.
31. Zhang Z., Yamashita H., Toyama T., Yamamoto Y., Kawasoe T., Iwase H. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin. Cancer Res. 2006, 12:6410-6414.
32. Lombardi G., Di Cristofano C., Capodanno A., Iorio M.C., Aretini P., Isola P., Tancredi M., Collecchi P., Naccarato A.G., Porta R.P., Bevilacqua G., Caligo M.A. High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis. Int. J. Cancer 2007, 120:1169-1178.
33. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003, 72:291-336.
34. Hurst D.R., Xie Y., Thomas J.W., Liu J., Edmonds M.D., Stewart M.D., Welch D.R. The C-Terminal Putative Nuclear Localization Sequence of Breast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression. PLoS One 2013, 8:e55966.
35. Hurst D.R., Welch D.R. Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression. FEBS Lett. 2011, 585:3185-3190.
36. Kapoor P., Saunders M.M., Li Z., Zhou Z., Sheaffer N., Kunze E.L., Samant R.S., Welch D.R., Donahue H.J. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int. J. Cancer 2004, 111:693-697.
37. Phadke P.A., Vaidya K.S., Nash K.T., Hurst D.R., Welch D.R. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. Am. J. Pathol. 2008, 172:809-817.
38. Hedley B.D., Vaidya K.S., Phadke P., MacKenzie L., Dales D.W., Postenka C.O., MacDonald I.C., Chambers A.F. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation. Clin. Exp. Metastasis 2008, 25:727-740.
39. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
40. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2:301-310.
41. Chapman N.R., Perkins N.D. Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. J. Biol. Chem. 2000, 275:4719-4725.
42. Wang J., An H., Mayo M.W., Baldwin A.S., Yarbrough W.G. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell 2007, 12:239-251.
43. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424:797-801.
44. Stafford L.J., Vaidya K.S., Welch D.R. Metastasis suppressors genes in cancer. Int. J. Biochem. Cell Biol. 2008, 40:874-891.
45. Riker A.I., Samant R.S. Location, location, location: The BRMS1 protein and melanoma progression. BMC Med. 2012, 10:19.
46. Slipicevic A., Holm R., Emilsen E., Ree Rosnes A.K., Welch D.R., Maelandsmo G.M., Florenes V.A. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. BMC Cancer 2012, 12:73.
47. Grzenda A., Lomberk G., Zhang J.S., Urrutia R. Sin3: master scaffold and transcriptional corepressor. Biochim. Biophys. Acta 2009, 1789:443-450.